Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:55:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The Publications section text was updated to clarify that publications are provided voluntarily by the person entering information about the study, and the revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:45:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice that previously warned users the site information may not be up to date or processed during funding gaps. The notice also advised users to check other sources for operating status.
    Difference
    0.4%
    Check dated 2025-11-18T06:54:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-11-03T20:57:46.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a prominent operating-status notice and links to status pages; indicates continuing government funding fluctuations may affect site responsiveness.
    Difference
    2%
    Check dated 2025-10-06T05:16:16.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:59:40.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.